ASTX Stock Quote - Astex Pharmaceuticals Inc Stock News, ResearchWarren Buffett Guru Investors

5.63 (1y: +250%)

Market Cap	516.7 M	P/E(ttm)	125.20
Enterprise Value	375.81 M	P/B	2.20

ASTX- NAS (USA)
Astex Pharmaceuticals Inc

Currently 1/5

Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$5.63

1 Severe Warning Sign 1 Medium Warning Sign 1 Good Sign

Bookmark

Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score

Market Cap $M	517	Revenue $M	83.2	Net Margin (%)	9.9	Z-Score	8.3
Enterprise Value $M	390	EPS $	0.1	Operating Margin %	-8.5	F-Score	4
P/E(ttm))	125	Cash Flow Per Share $	0.1	Pre-tax Margin (%)	-5.8	Higher ROA y-y	Y
Price/Book	2.2	10-y EBITDA Growth Rate %	0	Quick Ratio	3.9	Cash flow > Earnings	Y
Price/Sales	6.7	5-y EBITDA Growth Rate %	0	Current Ratio	5.7	Lower Leverage y-y	N
Price/Cash Flow	27.7	y-y EBITDA Growth Rate %	-125.0	ROA % (ttm)	3.0	Higher Current Ratio y-y	N
Dividend Yield %	0	Insider Buy (3m)	0	ROE % (ttm)	3.5	Less Shares Outstanding y-y	N
Payout Ratio %	0	Shares Outstanding M	93.7	ROI % (ttm)	-0.1	Gross Margin Increase y-y	N

Gurus Latest Trades with ASTX

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus

Number of guru portfolios checked: 51.

No Entry found!

Total Records: 0

ASTX is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus

Most recent portfolio changes are included for Premium Members only!

ASTX: Insider Buys/Sells

Click Here for All Insider Trades.

Insider	Position	Date	Trades	Shares	Trade Price ($)	Change (%)	Details
MANUSO JAMES S J	CEO	2013-05-14	Sell	29,500	$5.84	-3.6	view
CASAMENTO CHARLES J	Director	2013-05-03	Sell	71,000	$5.87	-4.09	view
MANUSO JAMES S J	CEO	2013-05-02	Sell	38,000	$5.87	-4.09	view
Jhoti Harren	President	2013-03-15	Sell	10,000	$4.25	32.47	view
CASAMENTO CHARLES J	Director	2013-03-13	Sell	14,000	$4.27	31.85	view
MANUSO JAMES S J	CEO	2013-03-08	Sell	40,000	$4.4	27.95	view

Press Releases about ASTX:

Astex Pharmaceuticals to Present at ROTH Conference 12 Mar 2013
Astex Pharmaceuticals to Present at RBC Capital Markets... 20 Feb 2013
Astex Pharmaceuticals to Announce 2012 Fourth Quarter and... 19 Feb 2013
Astex Pharmaceuticals to Present at BIO CEO & Investor... 05 Feb 2013
Cancer Research UK and Cancer Research Technology Initiate... 16 Jan 2013

Quarterly/Annual Reports about ASTX:

10-Q - SUPERGEN INC (0000919722) (Filer): (10-Q) 09 Aug 2011
10-Q - SUPERGEN INC (0000919722) (Filer): (10-Q) 10 May 2011
10-K - SUPERGEN INC (0000919722) (Filer): (10-K) 09 Mar 2011
10-K/A - SUPERGEN INC (0000919722) (Filer): (10-K/A) 08 Dec 2010
10-Q - SUPERGEN INC (0000919722) (Filer): (10-Q) 05 Nov 2010

News about ASTX:

Articles On GuruFocus.com

Add Notes, Comments or Ask Questions

Please log in first

Comments

No comment yet

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles